Lin Ning

Biotech investor/ PhD in neurobiology / Previously @Stanford Tweets #biotech 🔬 #neuroscience 🧠 #DeSci 🧬

[Tess van Stekelenburg @velvetatom]

We are in the early days of AI used as tool for biological design.

It’s potential to design new proteins + DNA sequences from the building blocks of life is astonishing.

Sat down w. @NatureBiotech to discuss the emerging field of Generative Biology.

https://t.co/6nAUDEZ7xw

[Lin Ning @Lightning5400]

The neurodegeneration space is heating up following the recent approval of Relyvrio and Leqembi. In my most recent blog post, I dive into the AD drug discovery with a focus on the amyloid pathway and what can we learn from the clinical trials. https://t.co/7qkHCO07vB

[Lin Ning @Lightning5400]

@MattStergiou Thank you, Matt!

[Lin Ning @Lightning5400]

@VaguelyProf @iankar_ @steviemctweets @Vol1Ventures We absolutely are. Here it is https://t.co/Cdfq0ON8sh

[Lin Ning @Lightning5400]

This show is brought to you by @Decil_Official and @SustainaDAO

[Lin Ning @Lightning5400]

A new episode of our podcast is online. In this episode, I had a great conversation with @iankar_ and @steviemctweets from @vol1ventures over #FTX, crypto regulation, and why it is critical to set up legal strategy correctly from Day 1 for startups. https://t.co/LLJmlON5zB

[Lin Ning @Lightning5400]

@Vol1Ventures is a pressed fund focusing on Fintech, crypto, and biotech. With their expertise in regulation and product dev, Vol1 makes every effort to help the portfolio to start off on the right foot from Day 1.

[Lin Ning @Lightning5400]

@ckriesi Thanks, ck! I’ll DM you.

[Lin Ning @Lightning5400]

I just posted part 2 of the article "Machine learning-powered drug discovery: Now and Tomorrow" in my newsletter. https://t.co/q54K4sRozX

[Lin Ning @Lightning5400]

@vasudevbailey Thanks for highlighting my work!

[Lin Ning @Lightning5400]

The first AI-derived drugs for neurodegeneration diseases just entered clinical trial! A big step for the CNS drug discovery. Keep up the good work @VergeGenomics

[Alice Zhang @AliceXinliZhang]

It has been a life-long dream of mine to take the promise of computational biology and turn it into a product for patients. I am proud to announce today that we have successfully dosed our first person in our first-in-human clinical trial of VRG50635. https://t.co/JeNNKqxaRS

[DECIL @Decil_Official]

Since the launch of the SustanaDAO Non-Fungible Talk Podcast on Sep. 7th, 2022, we are honored to provide high-quality web3 content to our 1st 500 listeners. The DECIL team and @SustainaDAO appreciate your support! We continue to work hard to offer value to the community. 🥳😇

[Lin Ning @Lightning5400]

The show is brought to you by @SustainaDAO @Decil_Official

[Lin Ning @Lightning5400]

SustainaDAO Non-Fungible Talk Ep7 is online. In this episode, I interviewed David Packham @GunnisonCap , the CEO and founder of Chintai @ChintaiNetwork. https://t.co/2Bkd5788Gr

[Lin Ning @Lightning5400]

Chintai is a leading blockchain tokenization platform in Singapore, and one of the few companies globally receiving the capital markets services (CMS) license from the Monetary Authority of Singapore (MAS) to conduct the regulated activity of dealing in capital markets products.

[Lin Ning @Lightning5400]

@Trim_Bot @GunnisonCap @ChintaiNetwork Thank you for the feedback!

[Lin Ning @Lightning5400]

I also spotted some emerging trends that will transform the way how we generate, manage and analyze data, and shape the future of drug discovery. Hope you enjoy reading it.
#ai #machinelearning #drugdiscovery #techbio #platforms #businessmodels #scaleup #multiomics #frameworks

[Lin Ning @Lightning5400]

In this post, I analyzed 40+ AI-first drug discovery companies and dived into key features (ie. platforms, business models, and scaleup) that make those companies unique.

[Jason Sheltzer @JSheltzer]

Pääbo's father, Sune Bergström, won the Nobel Prize in 1982 for his research on prostaglandins. This is the 8th time the prize has been awarded to the child of a previous winner.

[Lin Ning @Lightning5400]

Today ⁦@MelioraTx⁩ came out from the stealth with an announcement of $11M seed round. We are proud to back such a visionary team ⁦@davidycli⁩ ⁦@JSheltzer⁩ @Joans with incredible investors ⁦@HOFCapital⁩ ⁦@ZhenFund⁩ ⁦and others https://t.co/IzML6w65ZX